Latest Financial Results News

Harmoney Corp Limited has reported a strong first half of 2026, surpassing previous full-year profits and upgrading its FY26 cash NPAT guidance to $13 million, driven by loan book growth and automation advances.

FINEOS Corporation reports robust FY25 financial performance, driven by subscription revenue growth and embedded AI innovations, setting a confident outlook through FY27.

EML Payments has received Supreme Court approval for its $37.36 million shareholder class action settlement, enabling the company to refocus on its strategic growth plans.

Tuas Limited has reported a robust first half for FY26, with significant revenue and profit growth driven by expanding mobile and broadband subscribers, alongside progress on its strategic M1 acquisition.

Etherstack plc has secured a significant revenue uplift from a scope change in its primary UK government project, adding £1.53 million to its future earnings forecast for FY27.

Auric Mining has delivered a standout performance at its Munda Starter Pit, producing 46% more gold than budgeted and generating a net cash position of A$43.5 million. The results suggest a larger, higher-grade gold resource than previously estimated.

Clover Corporation has reported a robust first half for FY26, with revenue climbing 17% and margins expanding significantly, underpinning a confident revenue forecast for the full year.

Peppermint Innovation Limited reported a $1.27 million net loss for the half-year ending December 2025 while achieving key milestones including activation of national payment rails in the Philippines and settling a statutory demand that led to an ASX trading suspension.

Novo Resources Corp. reported a net loss of CAD 22.4 million for 2025, slightly improving from the previous year, while securing a $5.9 million capital raise to support ongoing exploration and operations.

Synlait confirms the imminent sale of its North Island assets to Abbott for NZ$307 million, aiming to reset its balance sheet amid a challenging half-year result. The company unveils a recovery roadmap focused on stabilising and scaling its core operations.

Synlait Milk Limited has reported a significant half-year loss driven by manufacturing setbacks and market pressures, alongside a strategic recovery roadmap focused on asset sales and operational overhaul.

CLINUVEL Pharmaceuticals reports record first-half profits and confirms CEO Philippe Wolgen’s leadership through a pivotal growth phase, prioritising its vitiligo program and Nasdaq ambitions.